A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects
Clinical trial NCT04083833 · COMPLETED
Trial details
- NCT number
- NCT04083833
- Sponsor
- Wex Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2018-03-24
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.